Ramucirumab 2026 - Joint Procurement
LP s obsahem ramucirumabu 2026 - sdružený nákup
Czechia · Olomouc - Nová Ulice · how to bid here →
Your path to submission
- Deadline: 23 October at 10:00 — 20 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: CES.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- 45% of this buyer's awards went to companies that had already won here before (2,864 awards since 2015, spread over 400 companies). That is well below the sector norm (69%) — this buyer switches suppliers more often than others.n = 2,864 awards since 2015
- The median procedure drew just one bid (2,123 procedures with a bid count); 60% ended with a single bidder. Sector: median 2 bids.n = 2,123
- 17% of awards went to companies from abroad (2,864 awards with a known winner country). Sector average: 10%.n = 2,864
- The award came in at a median 94% of the estimated value (560 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 93%.n = 560
- 1% of the bids received came from other countries (1,178 procedures with a bid mix) — all bidders, not just the winners. Sector: 1%.n = 1,178
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 02/10/2026.
Foreign bidders
In Czechia · Medical equipment & pharma, 101 contracts went to foreign companies over the last 3 years (of 16,917 recorded awards) — mostly from Germany, Poland, Austria.
Submission language: CES.
Typical field: median 1 (from 1,098 awards).
What the buyer is looking for
The subject of the public contract is the repeated supply of medicinal products meeting the requirements of SÚKL containing the active substance ramucirumab
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in Czech.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| PHOENIX lékárenský velkoobchod, s.r.o. | 145 | 2022–2026 |
| Alliance Healthcare s.r.o. | 140 | 2015–2026 |
| PROMEDICA PRAHA GROUP, a.s. | 59 | 2022–2026 |
| PHARMOS, a.s. | 57 | 2022–2026 |
| B. Braun Medical s.r.o. | 49 | 2022–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.